Cargando…
Associations of anemia persistency with medical expenditures in Medicare ESRD patients on dialysis
Most end-stage renal disease (ESRD) patients begin renal replacement therapy with hemoglobin levels below the recommended US National Kidney Foundation Dialysis Outcomes Quality Initiative Guidelines lower level of 110 g/L. Although most patients eventually reach this target, the time required varie...
Autores principales: | Liu, Jiannong, Guo, Haifeng, Gilbertson, David, Foley, Robert, Collins, Allan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690975/ https://www.ncbi.nlm.nih.gov/pubmed/19753126 |
Ejemplares similares
-
Comparative mortality of hemodialysis patients at for-profit and not-for-profit dialysis facilities in the United States, 1998 to 2003: A retrospective analysis
por: Foley, Robert N, et al.
Publicado: (2008) -
Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States
por: St. Peter, Wendy L., et al.
Publicado: (2018) -
Use of Home Health Care by ESRD and Medicare Beneficiaries
por: Kauf, Teresa L., et al.
Publicado: (1999) -
Risk-Adjustment System for the Medicare Capitated ESRD Program
por: Levy, Jesse M., et al.
Publicado: (2006) -
Predialysis anemia management and outcomes following dialysis initiation: A retrospective cohort analysis
por: Wetmore, James B., et al.
Publicado: (2018)